DLD Antikörper
Kurzübersicht für DLD Antikörper (ABIN2719487)
Target
Alle DLD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Homo sapiens dihydrolipoamide dehydrogenase (DLD)
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Full length human recombinant protein of human DLD(NP_000099) produced in HEK293T cell.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- WB 1:2000, IF 1:100, FLOW 1:100,
-
Kommentare
-
The concentration of the product may vary between diferrent lots.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- DLD (Dihydrolipoamide Dehydrogenase (DLD))
-
Andere Bezeichnung
- DLD
-
Hintergrund
- This gene encodes the L protein of the mitochondrial glycine cleavage system. The L protein, also named dihydrolipoamide dehydrogenase, is also a component of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acide dehydrogenase complex. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency.
-
Molekulargewicht
- 50.1 kDa
-
Gen-ID
- 1738
-
NCBI Accession
- NM_000108
-
HGNC
- 1738
-
Pathways
- Ribonucleoside Biosynthetic Process, Cell RedoxHomeostasis
Target
-